NCT01165632 - Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 26, 2010

Primary Completion Date

November 5, 2013

Study Completion Date

July 26, 2019

Conditions

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Diffuse AstrocytomaAdult EpendymomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaAdult Mixed GliomaAdult Myxopapillary EpendymomaAdult OligodendrogliomaAdult Pilocytic AstrocytomaAdult Pineal Gland AstrocytomaAdult Subependymal Giant Cell AstrocytomaAdult Subependymoma

Interventions

PROCEDURE

biopsy

Correlative studies

PROCEDURE

computed tomography

Undergo computed tomography

PROCEDURE

therapeutic conventional surgery

Undergo stereotactic craniotomy

RADIATION

radiation therapy treatment planning/simulation

Undergo radiation therapy treatment planning/simulation

RADIATION

radiation therapy

Undergo radiation therapy

PROCEDURE

magnetic resonance imaging

Undergo magnetic resonance imaging

PROCEDURE

positron emission tomography

Undergo positron emission tomography

DRUG

fluorine F 18 fluorodopa

Given IV

Trial Locations (1)

55905

Mayo Clinic, Rochester